BACKGROUND: Telomeres protect the ends of chromosomes, and shorter leukocyte telomeres are associated with poor health. Depression may be associated with the shortening of leukocyte telomeres. The present study set out to consolidate the varying effect sizes found so far in studies of depression and telomere length and to identify moderators of the relationship between depression and telomere length. METHODS: A meta-analytic investigation of the relationship between depression and leukocyte telomere length used information from 21,040 participants. RESULTS: A significant effect size, r = -.12, P < .001, indicated that depression was associated with shorter telomere length. Several variables significantly moderated effect size. Concurrent associations (k = 25) between depression and telomere length were significantly stronger than longitudinal associations (k = 5). Studies that used the Southern blot (k = 3) and fluorescent in situ hybridization (FISH; k = 2) assays to measure telomere length showed larger effect sizes than studies that used quantitative polymerase chain reaction (qPCR; k = 25). Finally, study reports that indicated that the telomere assays were conducted blind to depression level of participants (k = 11) had significantly lower effect sizes than those of other studies (k = 19). CONCLUSIONS: The significant relationship between depression and shorter telomere length is consistent with a theoretical model positing that distress, such as experienced in depression, results in physiological changes leading to shortened telomeres.
BACKGROUND: Telomeres protect the ends of chromosomes, and shorter leukocyte telomeres are associated with poor health. Depression may be associated with the shortening of leukocyte telomeres. The present study set out to consolidate the varying effect sizes found so far in studies of depression and telomere length and to identify moderators of the relationship between depression and telomere length. METHODS: A meta-analytic investigation of the relationship between depression and leukocyte telomere length used information from 21,040 participants. RESULTS: A significant effect size, r = -.12, P < .001, indicated that depression was associated with shorter telomere length. Several variables significantly moderated effect size. Concurrent associations (k = 25) between depression and telomere length were significantly stronger than longitudinal associations (k = 5). Studies that used the Southern blot (k = 3) and fluorescent in situ hybridization (FISH; k = 2) assays to measure telomere length showed larger effect sizes than studies that used quantitative polymerase chain reaction (qPCR; k = 25). Finally, study reports that indicated that the telomere assays were conducted blind to depression level of participants (k = 11) had significantly lower effect sizes than those of other studies (k = 19). CONCLUSIONS: The significant relationship between depression and shorter telomere length is consistent with a theoretical model positing that distress, such as experienced in depression, results in physiological changes leading to shortened telomeres.
Authors: Kathryn K Ridout; Samuel J Ridout; Lawrence H Price; Srijan Sen; Audrey R Tyrka Journal: J Affect Disord Date: 2015-12-02 Impact factor: 4.839
Authors: Naomi M Simon; Zandra E Walton; Eric Bui; Jennifer Prescott; Elizabeth Hoge; Aparna Keshaviah; Noah Schwarz; Taylor Dryman; Rebecca A Ojserkis; Benjamin Kovachy; David Mischoulon; John Worthington; Immaculata De Vivo; Maurizio Fava; Kwok-Kin Wong Journal: Psychoneuroendocrinology Date: 2015-04-13 Impact factor: 4.905
Authors: Laura K M Han; Moji Aghajani; Shaunna L Clark; Robin F Chan; Mohammad W Hattab; Andrey A Shabalin; Min Zhao; Gaurav Kumar; Lin Ying Xie; Rick Jansen; Yuri Milaneschi; Brian Dean; Karolina A Aberg; Edwin J C G van den Oord; Brenda W J H Penninx Journal: Am J Psychiatry Date: 2018-04-16 Impact factor: 18.112
Authors: Laura K M Han; Josine E Verhoeven; Audrey R Tyrka; Brenda W J H Penninx; Owen M Wolkowitz; Kristoffer N T Månsson; Daniel Lindqvist; Marco P Boks; Dóra Révész; Synthia H Mellon; Martin Picard Journal: Psychoneuroendocrinology Date: 2019-04-05 Impact factor: 4.905
Authors: Stefanie E Mayer; Aric A Prather; Eli Puterman; Jue Lin; Justine Arenander; Michael Coccia; Grant S Shields; George M Slavich; Elissa S Epel Journal: Psychoneuroendocrinology Date: 2019-03-05 Impact factor: 4.905
Authors: J E Verhoeven; D Révész; M Picard; E E Epel; O M Wolkowitz; K A Matthews; B W J H Penninx; E Puterman Journal: Mol Psychiatry Date: 2017-03-28 Impact factor: 15.992
Authors: Mary C Vance; Eric Bui; Susanne S Hoeppner; Benjamin Kovachy; Jennifer Prescott; David Mischoulon; Zandra E Walton; Melissa Dong; Mireya F Nadal; John J Worthington; Elizabeth A Hoge; Paolo Cassano; Esther H Orr; Maurizio Fava; Immaculata de Vivo; Kwok-Kin Wong; Naomi M Simon Journal: Psychoneuroendocrinology Date: 2018-02-21 Impact factor: 4.905
Authors: Alessio Squassina; Mirko Manchia; Claudia Pisanu; Raffaella Ardau; Carlo Arzedi; Alberto Bocchetta; Paola Caria; Cristina Cocco; Donatella Congiu; Eleonora Cossu; Tinuccia Dettori; Daniela Virginia Frau; Mario Garzilli; Elias Manca; Anna Meloni; Maria Antonietta Montis; Andrea Mura; Mariella Nieddu; Barbara Noli; Pasquale Paribello; Federica Pinna; Renato Robledo; Giovanni Severino; Valeria Sogos; Maria Del Zompo; Gian Luca Ferri; Caterina Chillotti; Roberta Vanni; Bernardo Carpiniello Journal: Neuropsychopharmacology Date: 2020-09-12 Impact factor: 7.853